Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China
· Delayed Price · Currency is CNY 19.24
+0.17 (0.89%)
At close: Mar 6, 2026
SHE:301408 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Market Capitalization | 7,572 | 4,412 | 6,380 | - | - | - | Upgrade
|
| Market Cap Growth | 67.82% | -30.85% | - | - | - | - | Upgrade
|
| Enterprise Value | 8,183 | 4,579 | 6,088 | - | - | - | Upgrade
|
| Last Close Price | 18.93 | 10.94 | 15.67 | - | - | - | Upgrade
|
| PE Ratio | 41.11 | 32.04 | 55.64 | - | - | - | Upgrade
|
| PS Ratio | 1.47 | 0.97 | 1.68 | - | - | - | Upgrade
|
| PB Ratio | 3.51 | 2.14 | 3.23 | - | - | - | Upgrade
|
| P/TBV Ratio | 11.19 | 4.65 | 5.02 | - | - | - | Upgrade
|
| P/FCF Ratio | 11.87 | 10.81 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 9.86 | 7.72 | 48.57 | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.59 | 1.01 | 1.60 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 13.46 | 17.47 | 35.41 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 26.95 | 20.51 | 40.46 | - | - | - | Upgrade
|
| EV/FCF Ratio | 12.83 | 11.21 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.65 | 0.60 | 0.65 | 0.81 | 0.76 | 0.16 | Upgrade
|
| Debt / EBITDA Ratio | 2.32 | 2.38 | 3.58 | 1.94 | 2.23 | 0.85 | Upgrade
|
| Debt / FCF Ratio | 2.21 | 3.00 | - | 11.03 | 5.59 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.25 | 0.11 | -0.03 | 0.30 | 0.40 | -0.17 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.54 | 0.82 | -0.36 | 1.17 | 1.17 | -0.92 | Upgrade
|
| Net Debt / FCF Ratio | 0.86 | 0.53 | 0.70 | 4.05 | 2.93 | 4.61 | Upgrade
|
| Asset Turnover | 1.00 | 0.96 | 1.06 | 1.44 | 1.44 | 1.64 | Upgrade
|
| Inventory Turnover | 3.69 | 3.75 | 4.01 | 4.50 | 4.13 | 4.63 | Upgrade
|
| Quick Ratio | 0.59 | 0.70 | 0.97 | 0.73 | 0.69 | 0.84 | Upgrade
|
| Current Ratio | 1.09 | 1.19 | 1.44 | 1.25 | 1.26 | 1.62 | Upgrade
|
| Return on Equity (ROE) | 9.93% | 7.54% | 8.05% | 18.50% | 9.30% | 14.14% | Upgrade
|
| Return on Assets (ROA) | 3.67% | 2.96% | 2.62% | 6.26% | 4.11% | 6.47% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.43% | 7.90% | 7.44% | 14.62% | 9.37% | 15.76% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.60% | 8.40% | 5.70% | 18.70% | 9.80% | 17.00% | Upgrade
|
| Earnings Yield | 2.46% | 3.12% | 1.80% | - | - | - | Upgrade
|
| FCF Yield | 8.42% | 9.25% | -1.41% | - | - | - | Upgrade
|
| Dividend Yield | 0.52% | 0.91% | 0.64% | - | - | - | Upgrade
|
| Payout Ratio | 30.42% | 40.66% | 12.81% | 2.57% | 6.23% | 7.77% | Upgrade
|
| Buyback Yield / Dilution | 0.10% | -2.43% | -15.59% | -3.02% | 2.92% | -5.34% | Upgrade
|
| Total Shareholder Return | 0.62% | -1.51% | -14.95% | -3.02% | 2.92% | -5.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.